Compare WKHS & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WKHS | COCH |
|---|---|---|
| Founded | 2007 | 1995 |
| Country | United States | United States |
| Employees | 148 | N/A |
| Industry | Auto Manufacturing | Blank Checks |
| Sector | Consumer Discretionary | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.8M | 51.0M |
| IPO Year | 2008 | 2021 |
| Metric | WKHS | COCH |
|---|---|---|
| Price | $2.94 | $0.70 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $21.00 | $6.00 |
| AVG Volume (30 Days) | ★ 98.1K | 50.5K |
| Earning Date | 05-14-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 86.92 | 17.45 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $763,173.00 | $241,000.00 |
| Revenue This Year | $89.23 | $1.58 |
| Revenue Next Year | $28.84 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 7.11 |
| 52 Week Low | $0.53 | $0.36 |
| 52 Week High | $11.80 | $1.89 |
| Indicator | WKHS | COCH |
|---|---|---|
| Relative Strength Index (RSI) | 44.30 | 46.24 |
| Support Level | $2.80 | $0.63 |
| Resistance Level | $3.56 | $0.74 |
| Average True Range (ATR) | 0.13 | 0.03 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 26.75 | 32.11 |
Workhorse Group Inc is a technology company with a vision to pioneer the transition to zero-emission commercial vehicles. Its focus is to provide sustainable and cost-effective solutions to the commercial transportation sector. It designs and manufactures all-electric vehicles, including the technology that optimizes the way these vehicles operate. It's focused on a core competency of bringing electric delivery vehicle platforms to serve the last-mile delivery market. Its products are marketed under the Workhorse brand.
Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.